Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Systemic tissue hypoxia is a medical condition characterized by an inadequate supply of oxygen to tissues throughout the body, which can result from causes such as hypoxemia (low oxygen in blood), anemia (low oxygen-carrying capacity), circulatory failure (impaired oxygen delivery), or inability of tissues to utilize oxygen (histotoxic hypoxia). It triggers adaptive and pathological cellular processes, including a shift toward anaerobic metabolism, increased lactate production, and upregulation of hypoxia-inducible factors, leading to sustained physiological and sometimes pathological responses. Systemic hypoxia is central to the pathophysiology of many acute and chronic diseases, notably in critical care, cardiovascular dysfunction, cancer progression, and chronic respiratory diseases.
Approaches are supportive and mechanism may involve improving oxygen delivery (supplemental oxygen, increasing cardiac output), increasing blood oxygen carrying capacity (blood transfusion), or treating the underlying cause (e.g., antibiotics, antitoxins, anticoagulants)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Systemic tissue hypoxia.